Pityriasis versicolor alba

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 2, 2005, Pages 147-152

  Thoma, Wiebke ^a   Kramer H J ^a   Mayser, P ^a  

^a Center for Dermatology and Andrology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE DERIVATIVE; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; METHOXSALEN; PYRROLE DERIVATIVE; TRYPTOPHAN;

CELL MATURATION; DEPIGMENTATION; DISEASE DURATION; ELECTRON MICROSCOPY; EVIDENCE BASED MEDICINE; FUNGAL METABOLISM; HISTOPATHOLOGY; HUMAN; HYPOPIGMENTATION; MALASSEZIA; MALASSEZIA FURFUR; MALASSEZIA PACHYDERMATIS; MELANOSOME; PATHOGENESIS; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SEBORRHEA; SKIN PIGMENTATION; SPECIES DIFFERENCE; TINEA VERSICOLOR; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; HISTORY, 19TH CENTURY; HUMANS; KETOCONAZOLE; MALASSEZIA; MICROSCOPY, ELECTRON; SKIN; SKIN PIGMENTATION; TINEA VERSICOLOR; ULTRAVIOLET THERAPY;

EID: 16244411705     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.01085.x     Document Type: Review

References (69)

1. Sunenshine PJ, Schwartz RA, Janniger CK. Tinea versicolor. Int J Dermatol 1998; 37: 648-655.
2. Gupta AK, Bluhm R, Summerbell R. Pityriasis versicolor. J Eur Acad Dermatol Venereol 2002; 16: 19-33.
3. Midgley G. The lipophilic yeasts: state of the art and prospects. Med Mycol 2000; 38 (Suppl. 1): 9 -16.
4. Hay RJ, Roberts SOB, Mackenzie DWR. Pityriasis versicolor. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology Vol. 2, 6th edn. Blackwell Scientific Publications, Oxford, 1998: 1286-1290.
5. Crespo Erchiga V, Ojeda Martos A, Casana Vera A et al. Malassezia globosa as the causative agent of pityriasis versicolor. Br J Dermatol 2000; 143: 799-803.
6. Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrheic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000; 38: 337-341.
7. Pardo-Castello V. Achromia parasitaria. Arch Dermatol Syphiligr 1932; 25: 785-789.
8. Jeliffe DB, Jacobson FW. The clinical picture of tinea versicolor in negro infants. J Trop Med Hyg 1954; 57: 290-293.
9. Marples MJ. The incidence of certain skin diseases in Western Samoa: a preliminary survey. Trans R Soc Trop Med Hyg 1950; 44 319-322.
10. Nazzaro Porro M, Passi S, Picardo M et al. Lipoxygenase activity of Pityrosporum in vitro and vivo. J Invest Dermatol 1986; 87: 108-112.
11. De Luca C, Picardo M, Breathnach A, Passi S. Lipoperoxidase activity of Pityrosporum: characterisation of by-products and possible role in pityriasis versicolor. Exp Dermatol 1996; 5: 49-56.
12. Keddie FM. Tinea versicolor, 1846-1900. A historical survey based on selections from the writings of the nineteenth century. In: Robinson Jr, ed. The Diagnosis and Treatment of Fungal Infections. Thomas CC, Springfield, IL, 1974: 169-184.
13. Naylor G. A Practical and Theoretical Treatise on the Diseases of the Skin. London, 1866: 46-50.
14. Lutz A. Korrespondenz. Honolulu, September 1891. Mh Prakt Dermatol 1892; 14: 152-155.
15. Adamson HG. Pityriasis versicolor with subsequent leukodermic patches. Br J Dermatol 1949; 61: 322-322.
16. Lockshin NA. Tinea versicolor masquerading as vitiligo. Cutis 1973; 12: 245-247.
17. Moynahan EJ. Pityriasis versicolor alba (speckled torso syndrome) and Mediterranean holidays. Lancet 1976; 2: 471-472.
18. El-Gothamy Z, Abdel-Fattah AF. Tinea versicolor hypopigmentation: histochemical and therapeutic studies. Int J Dermatol 1975; 14: 510-515.
19. Bouassida S, Boudaya S, Ghorbel R et al. Pityriasis versicolor in children: a retrospective study of 164 cases. Ann Dermatol Venereol 1998; 125: 581-584.
20. Ruete AE. Zur Frage der depigmentierenden Pityriasis versicolor. Dermatol Wochenschr 1933; 96: 333-336.
21. Throne B. Achromia postparasitaria. Arch Dermatol Syphiligr 1928; 18: 148.
22. Artom M. Contributo allo studio della pityriasis versicolor acromizzante. G Ital Dermatol Sifiligr 1930; 71: 45.
23. Barney RE. Pseudo-Achromia Postparasitaria-Tinea versicolor. Arch Dermatol Syphiligr 1932; 25: 1167.
24. Kistiakovsky EV. Pityriasis versicolor and ultraviolet rays. Arch Dermatol Syphiligr 1927; 15: 685-689.
25. Jung EG, Bohnert E. Mechanism of depigmentation on pityriasis versicolor alba. Arch Dermatol Res 1976; 256: 333-334.
26. Wertheim L. Über Lichtwirkung und Leukoderma bei Pityriasis versicolor. Dermatol Z 1928; 38: 343-354.
27. Mc Ginley KJ, Lantis LR, Marples RR. Microbiology of tinea versicolor. Arch Dermatol 1970; 102: 168-171.
28. Chatterji A. Observation on dopa reaction in the lesions of pityriasis versicolor. Indian J Dermatol 1972; 17: 94-95.
29. Charles CR, Sire DJ, Johnson BL, Beidler JG. Hypopigmentation in tinea versicolor: a histochemical and electronmicroscopic study. Int J Dermatol 1973; 12: 48-58.
30. Galadari I, El Komy M. Tinea versicolor: histologic and ultrastructural investigation of pigmentary changes. Int J Dermatol 1992; 31: 253-256.
31. Lewis GM. Tinea versicolor (white). Arch Dermatol Syphiligr 1935; 31: 911-913.
32. Besnier E, Balzer F. Les dermatomycoses. Gaz Hebdom Med Chir 1882; 19: 326-328, 341-344.
33. Lewis GM, Hopper ME. Pseudoachromia of tinea versicolor. Arch Dermatol Syphiligr 1936; 34: 850-861.
34. Noble WC. Microbiology of Human Skin. Lloyd-Duke, London, 1981; 3-65, 263-268.
35. Tosti A, Villardita S, Fazzini ML. The parasitic colonization of the horny layer in tinea versicolor. J Invest Dermatol 1972; 59: 223-237.
36. Marks R, Dawber RPR. In situ microbiology of the stratum corneum. Arch Dermatology 1972; 105: 216-221.
37. Ashbee HR, Evans GV. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev 2002; 15: 21-57.
38. Roberts SOB. Pityriasis versicolor: a clinical and mycological investigation. Br J Dermatol 1969; 81: 315-326.
39. Breathnach AS, Nazzaro-Porro M, Martin B. Ultrastructure of skin in pityriasis versicolor. G Ital Dermatol 1975; 110: 457-469.
40. Karaoui R, Bou-Resli M, Al-Zaid NS. Tinea versicolor: ultrastructural studies on hypopigmented and hyperpigmented skin. Dermatologica 1981; 162: 69-85.
41. Allen HB, Charles CR, Johnson BL. Hyperpigmented tinea versicolor. Arch Dermatol 1972; 112: 1110-1112.
42. Blumenthal H. Tinea versicolor of the penis. Arch Dermatol 1971; 103: 461-462.
43. Nia AK, Smith EL. Pityriasis versicolor of the glans penis. Br J Vener Dis 1979; 55: 230.
44. Goldsmith LA, ed. Physiology, Biochemistry and Molecular Biology of the Skin, 2nd edn. Oxford University Press, New York, 1990.
45. Nazzaro-Porro M, Passi S, Caprilli F, Mercantini R. Induction of hyphae in cultures of Pityrosporum by cholesterol and cholesterol esters. J Invest Dermatol 1977; 69: 531-534.
46. Bojanowsky A, Bohnert E, Jung EG. Pityrosporum orbiculare: Erreger verschiedener klinischer Bilder und Modell einer Depigmentierungsart. Act Dermatol 1979; 5: 19-25.
47. Breathnach AS, Nazzaro-Porro M, Passi S. Azelaic acid. Br J Dermatol 1984; 111: 115-120.
48. Robins EJ, Breathnach AS, Bennet D et al. Ultrastructural observations on the effect of azelaic acid on normal human melanocytes and human melanoma cell line in tissue culture. Br J Dermatol 1987; 113: 687-697.
49. Mayser P, Wille G, Imkampe A et al. Synthesis of fluorochromes and pigments in Malassezia furfur by use of tryptophan as single nitrogen source. Mycoses, 1998; 41: 265-271.
50. Wille G, Mayser P, Thoma W et al. Isolation and synthesis of malassezin - An agonist of the arylhydrocarbon receptor from the yeast Malassezia furfur. J Bioorg Med Chem 2001; 9: 955-960.
51. Mayser P, Schäfer U, Krämer HJ et al. Pityriacitrin-un ultraviolet-absorbing from the yeast Malassezia furfur. Arch Dermatol Res 2002; 294: 131-134.
52. Mayser P, Stapelkamp H, Kramer HJ et al. Pityrialactone - a new fluorochrome from the tryptophan metabolism of Malassezia furfur. Antonie Van Leeuwenhoek 2003; 84: 185-91.
53. Thoma W, Trinkaus M, Mayser P. Identifikation eines Tyrosinase-Inhibitiors im Stoffwechsel von Malassezia furfur. Mycoses 2000; 43: 264.
54. Thoma W, Trinkaus M, Mayser P. Tyrosinaseinhibition durch Stoffwechselprodukte von M. furfur. Haut- und Geschlechtsk-rankheiten 2000; 75: 473.
55. Thoma W, Dahms K, Krämer HJ et al. Tyrosinaseinhibition durch KO27-einen Stoffwechselmetaboliten von Malassezia furfur. Mycoses 2001; 44: 238-239.
56. Dahms K, Krämer HJ, Thoma W, Mayser P. Tyrosinaseinhibition durch Tryptophanmetabolite von Malassezia furfur in humaner Epidermis. Mycoses 2002; 45: 230.
57. Podobinska M, Krämer HJ, Bartsch A et al. A cytotoxic metabolite from Malassezia furfur. Isolation and chemical identification as malassezin. Arch Dermatol Res 2003; 294: 512.
58. Mayser P, Pape B. Decreased susceptibility of Malassezia furfur to UV light by synthesis of tryptophan derivatives. Antonie van Leeuvenhook 1998; 73: 315-319.
59. Keddie FM. Tinea versicolor, 1846-1900. A historical survey based on selections from the writings of the nineteenth century. In: Robinson Jr, ed. The Diagnosis and Treatment of Fungal Infections. CC Thomas, Springfield IL, 1974: 169-184.
60. Mayser P, Töws A, Krämer HJ, Weiß R. Further characterization of pigment-producing Malassezia strains. Mycoses 2004; 47: 34-39.
61. Aspiroz C, Ara M, Varea M et al. Isolation of Malassezia globosa and M. sympodialis from patients with pityriasis versicolor in Spain. Mycopathologia 2002; 154(3): 111-117.
62. Villars V, Jones TC. Clinical efficacy and tolerability of terbinafine (Lamisil) - a new topical and systemic fungicidal drug for treatment of dermatomycoses. Clin Exp Dermatol 1989; 14: 124-127.
63. Meisel C. 10 Tage-Therapie der Pityriasis versicolor mit Ketokonazol. Z Hautkr 1983; 58: 1130-1136.
64. Hay R, Midgley G. Short course ketoconazole therapy in pityriasis versicolor. Clin Exp Dermatol 1984; 9: 571-573.
65. Kose O, Bulent Tastan H, Riza Gur A et al. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor. J Dermatol Treat 2002; 13 2): 77-79.
66. Shumer A, Nathanson N, Kaplan B et al. Itraconazole versus ketoconazole in the treatment of tinea versicolor. J Dermatol Treat 1999; 104: 11-23.
67. Faergemann J. Treatment of pityriasis versicolor with a single dose of fluconazole. Acta Dermatol 1992; 72: 74-5.
68. Rausch LJ, Jacobs PH. Tinea versicolor: treatment and prophylaxis with ketoconazole. Cutis 1984; 27: 470-471.
69. Faergemann J, Gupta AK, Al Mofadi A et al. The efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor. Arch Dermatol 2002; 138: 69-73.